Mohamed Abdel-Samiee, Mohamed I Youssef, Fathy Elghamry, Mahmoud Bazeed, Mohamed Al-Shorbagy, Helmy Shalaby, Hossam Shabana, Eman Abdelsameea, Hesham El Sayed Lashin, Hossam M Farid El Zamek, Tarek Esam, Mohammad AbdElhameed Ahmed Alwaseef, Housam Ahmed Helmy, Feras Almarshad, Fatma A Khalaf, Badawy W AboBakr Yossef, Arafat Kassem, Basant Mostafa Gabr, Ahmed Abdelfattah, Hind S AboShabaan, Galal Abdelhameed Aboufarrag, Marwa M Omar, Mohammed Saied Bakeer, Mohammed S Imam, Essam S Ibrahim, Shimaa Y Kamel, Talaat Allisy, Omima Sayed Mohammed, Ali Farahat, Mohsen M El-Khayat, Mohamed Abdelrafaa Hassan Sekeen, Eman Mohammed Zaher, Ashraf Said, Ahmed Abuamer, Essam Elmahdi
The infection caused by the hepatitis C virus (HCV) is a significant global health concern. The prevailing genotype of HCV in Egypt is 4a, commonly referred to as GT-4a. A significant proportion exceeding 50% of patients infected with HCV experience extrahepatic manifestations (EHMs), encompassing a diverse range of clinical presentations. These manifestations, including essential mixed cryoglobulinemia (MC), can serve as initial and solitary indicators of the disease. The complete understanding of the pathogenesis of EHM remains unclear, with autoimmune phenomena being recognized as the primary causative factor...
December 2023: Journal of Medical Virology